United Therapeutics Corporation Patents – Key Insights and Stats

United Therapeutics Corporation has a total of 1017 patents globally, out of which 494 have been granted. Of these 1017 patents, more than 57% patents are active. The United States of America is where United Therapeutics Corporation has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States of America seems to be the main focused R&D center and also is the origin country of United Therapeutics Corporation.

United Therapeutics Corporation was founded in 1996 by Martine A. Rothblatt. United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease. The Company’s lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously. As of August 2022, United Therapeutics Corporation has a market cap of $10.31 Billion.

Do read about some of the most popular patents of United Therapeutics Corporation which have been covered by us in this article and also you can find United Therapeutics Corporation patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over United Therapeutics Corporation patent portfolio.

How many patents does the Founder and CEO of United Therapeutics Corporation have?

The Founder and CEO Martine A. Rothblatt have 85 patents.

How many patents does United Therapeutics Corporation have?

United Therapeutics Corporation has a total of 1017 patents globally. These patents belong to 172 unique patent families. Out of 1017 patents, 582 patents are active.

How Many Patents did United Therapeutics Corporation File Every Year?

United Therapeutics Corporation Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantUnited Therapeutics Applications FiledUnited Therapeutics Patents Granted
20114615
20124816
20135022
20146735
20157443
20163135
20175636
20185061
20195046
20204135
20213336
20221127

How many United Therapeutics Corporation patents are Alive/Dead?

Worldwide Patents

United Therapeutics Corporation Patents Portfolio

How Many Patents did United Therapeutics Corporation File in Different Countries?

United Therapeutics Worldwide Corporation Patents

Countries in which United Therapeutics Corporation Filed Patents

CountryPatents
United States Of America224
Japan102
Europe101
China85
Canada77
Korea (South)63
Spain55
Germany55
India54
Australia44
Israel19
Austria13
New Zealand11
Hong Kong (S.A.R.)8
Denmark7
Portugal5
Mexico1
Singapore1
Brazil1
Poland1
Taiwan1

Where are Research Centers of United Therapeutics Corporation Patents Located?

Research Centers of United Therapeutics Corporation Patents

10 Best United Therapeutics Corporation Patents

US6521212B1 is the most popular patent in the United Therapeutics Corporation portfolio. It has received 185 citations so far from companies like Insmed Incorporated, Nexien Biopharma Inc, and Respira Therapeutics Inc.

Below is the list of 10 most cited patents of United Therapeutics Corporation:

Publication NumberCitation Count
US6521212B1185
US7417070B2175
US6441245B1161
US7384978B2160
US6756033B2154
US6809223B2153
US6700025B2147
US20080200449A1140
US6528688B2139
US7199157B2137

What Percentage of United Therapeutics Corporation US Patent Applications were Granted?

United Therapeutics Corporation (Excluding its subsidiaries) has filed 135 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 67 have been granted leading to a grant rate of 65.05%.

Below are the key stats of United Therapeutics Corporation patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for United Therapeutics Corporation?

Law FirmTotal ApplicationsSuccess Rate
Foley & Lardner Llp9563.77%
Ropes & Gray Llp1250.00%
Allen R Kipnes566.67%
Fish & Richardson Pc3100.00%
Morse Barnes Brown & Pendleton Pc2100.00%
Mr Nick C Bassil20.00%
Pillsbury Winthrop Shaw Pittman Llp250.00%
Sterne Kessler Goldstein & Fox Pllc2100.00%
Verrill20%
Widerman Malek Pl2100.00%

EXCLUSIVE INSIGHTS COMING SOON!

What are United Therapeutics Corporation key innovation segments?

What Technologies are Covered by United Therapeutics Corporation?

The chart below distributes patents filed by United Therapeutics Corporation in different countries on the basis of the technology protected in patents. It also represents the markets where United Therapeutics Corporation thinks it’s important to protect particular technology inventions.

R&D Focus: How has United Therapeutics Corporation search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by United Therapeutics Corporation?

Updated on August 29, 2022

Was this article helpful?

Leave a Comment